|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | China-Biotics, Inc. (OTCBB:OTRS), Shanghai based manufacturer of probiotics products. |
|---|---|
| Transferring Party | Sinosmart Group Inc., a holding company that owns 100% of a Shanghai based producer of probiotic dietary supplements. |
| Sector | Biopharmaceuticals |
| Date | March 31, 2006 |
| Analysis Enables China-Bioteics to further penetrate the Chinese probiotics marketplace and capitalize on the rapidly growing demand for domestically produced, bulk probiotic additives (bacteria that exist naturally in the human body believed to be necessary for intestinal tract health). Stock deal -- approx. 16m China-biotics shares issued. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |